Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
Atrial Fibrillation, Hemostasis
About this trial
This is an interventional supportive care trial for Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria: Must be at least 18 years of age Be able to provide consent Presenting for planned procedures that require percutaneous venous punctures, such as atrial fibrillation radiofrequency ablation, and where the physician utilizes a LockeT device or MC to close the wound. Exclusion Criteria: Under the age of 18 Unable to or unwilling to provide consent Cannot comply with study requirements Not undergoing procedures that require a percutaneous venous puncture or planned access to the left atrium and/or ventricle Subjects whose physician does not use LockeT or MC to close the venous puncture. Patient is currently pregnant, as evidenced by positive urine Beta-HCG. (Urine Beta Human chorionic gonadotropin (HCG) will be checked in all females of the reproductive age group). If the physician detects a formed hematoma prior to venous closure, that patient will be excluded from the study.
Sites / Locations
- Kansas City Heart Rhythm Institute - Roe ClinicRecruiting
- Overland Park Regional Medical CenterRecruiting
- Centerpoint Medical Center ClinicRecruiting
- Centerpoint Medical CenterRecruiting
- Research Medical Center ClinicRecruiting
- Research Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
LockeT
Manual compression
These are the patients assigned for LockeT device arm to close the access site wound.
These are the patients assigned for Manual Compression arm to close the access site wound.